| Shanghai Medpep Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (21) 6556-6949 | |||
![]() |
medpep@gmail.com xueminguo@hotmail.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2006 | ||||
| Shanghai Longschem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (21) 3635-6756 | |||
![]() |
charles-hu@longschem.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2007 | ||||
| KKyemistry (India) Pvt. Ltd. | India | Inquire | ||
|---|---|---|---|---|
![]() |
+91 (40) 2351-0950 | |||
![]() |
info@kyemistryindia.com | |||
| Chemical manufacturer since 2009 | ||||
| chemBlink standard supplier since 2010 | ||||
| Trignokem International | India | Inquire | ||
|---|---|---|---|---|
![]() |
+91 (40) 2717-0709 | |||
![]() |
info@trignokem.com | |||
| Chemical manufacturer since 2010 | ||||
| chemBlink standard supplier since 2014 | ||||
| Hangzhou Leap Chem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8771-1850 | |||
![]() |
market19@leapchem.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink standard supplier since 2015 | ||||
| Amadis Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8992-5085 | |||
![]() |
sales@amadischem.com | |||
| Chemical manufacturer since 2010 | ||||
| chemBlink standard supplier since 2015 | ||||
| Kemprotec Limited | UK | Inquire | ||
|---|---|---|---|---|
![]() |
+44 (1642) 591-764 | |||
![]() |
sales@kemprotec.co.uk | |||
| Chemical distributor since 1998 | ||||
| Classification | API >> Nervous system medication >> Sedative and hypnotics |
|---|---|
| Name | Eszopiclone |
| Synonyms | 4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester |
| Molecular Structure | ![]() |
| Molecular Formula | C17H17ClN6O3 |
| Molecular Weight | 388.81 |
| CAS Registry Number | 138729-47-2 |
| EC Number | 620-471-1 |
| Hazard Symbols |
Xn Details | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Codes | R20/21/22;R36/37/38;R62 Details | ||||||||||||||||||||||||||||||||||||||||||||
| Safety Description | S26;S36 Details | ||||||||||||||||||||||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Eszopiclone |